BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 31020952)

  • 1. Characterization of mRNA Expression and Endogenous RNA Profiles in Bladder Cancer Based on The Cancer Genome Atlas (TCGA) Database.
    Xu Z; Wang C; Xiang X; Li J; Huang J
    Med Sci Monit; 2019 Apr; 25():3041-3060. PubMed ID: 31020952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioinformatic and integrated analysis identifies an lncRNA-miRNA-mRNA interaction mechanism in gastric adenocarcinoma.
    Liao Y; Cao W; Zhang K; Zhou Y; Xu X; Zhao X; Yang X; Wang J; Zhao S; Zhang S; Yang L; Liu D; Tian Y; Wu W
    Genes Genomics; 2021 Jun; 43(6):613-622. PubMed ID: 33779949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction and identification of lncRNA/circRNA-coregulated ceRNA networks in gemcitabine-resistant bladder carcinoma.
    Pan J; Xie X; Sheng J; Ju C; Sun S; Cui F; Zhai W; Ming L
    Carcinogenesis; 2023 Dec; 44(12):847-858. PubMed ID: 37787763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A risk model based on lncRNA-miRNA-mRNA gene signature for predicting prognosis of patients with bladder cancer.
    Zhao ZY; Cao Y; Wang HL; Liu LY
    Cancer Biomark; 2024; 39(4):277-287. PubMed ID: 38306023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for key lncRNAs in the progression of gallbladder cancer using bioinformatics analyses.
    Zhang L; Geng Z; Meng X; Meng F; Wang L
    Mol Med Rep; 2018 May; 17(5):6449-6455. PubMed ID: 29512694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrative analysis of competing endogenous RNA network focusing on long noncoding RNA associated with progression of cutaneous melanoma.
    Xu S; Sui J; Yang S; Liu Y; Wang Y; Liang G
    Cancer Med; 2018 Apr; 7(4):1019-1029. PubMed ID: 29522273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of autophagy and angiogenesis modulators in colorectal cancer based on bioinformatics analysis.
    Shakeri F; Mohamadynejad P; Moghanibashi M
    Nucleosides Nucleotides Nucleic Acids; 2024; 43(4):340-355. PubMed ID: 37791824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Identification of lncrnas associated with aniline toxicity in male bladder cancer and construction of tumor risk prediction models].
    Jiang Q; Wei ZF; Xiong Y; Jiang B; Yao AB
    Zhonghua Nan Ke Xue; 2023 Sep; 29(9):790-798. PubMed ID: 38639590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptome-wide 1-methyladenosine functional profiling of messenger RNA and long non-coding RNA in bladder cancer.
    Yin JJ; Song YL; Guo YF; Dai YH; Chang Q; Wang T; Sun GQ; Lu P; Song DK; Zhang LR
    Front Genet; 2024; 15():1333931. PubMed ID: 38482382
    [No Abstract]   [Full Text] [Related]  

  • 10. SUDAZFLNC - a curated and searchable online database for zebrafish lncRNAs, mRNAs, miRNAs, and circadian expression profiles.
    Mishra SK; Wang H
    Comput Struct Biotechnol J; 2024 Dec; 23():1844-1853. PubMed ID: 38707541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioinformatics Analysis of the Expression of Key Long Intergenic Non-Protein Coding RNA Genes in Bladder Cancer.
    Lin YZ; Wu YP; Ke ZB; Cai H; Chen DN; Chen SH; Li XD; Lin TT; Huang JB; Zheng QS; Xue XY; Xu N; Wei Y
    Med Sci Monit; 2020 Apr; 26():e920504. PubMed ID: 32277695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new ferroptosis-related signature model including messenger RNAs and long non-coding RNAs predicts the prognosis of gastric cancer patients.
    Liu Y; Liu Y; Ye S; Feng H; Ma L
    J Transl Int Med; 2023 Jun; 11(2):145-155. PubMed ID: 38025952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homeobox Gene Expression Dysregulation as Potential Diagnostic and Prognostic Biomarkers in Bladder Cancer.
    Chin FW; Chan SC; Veerakumarasivam A
    Diagnostics (Basel); 2023 Aug; 13(16):. PubMed ID: 37627900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In Silico Methods for Identification of Potential Active Sites of Therapeutic Targets.
    Liao J; Wang Q; Wu F; Huang Z
    Molecules; 2022 Oct; 27(20):. PubMed ID: 36296697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncogenic roles of the lncRNA LINC00460 in human cancers.
    Su M; Tang J; Yang D; Wu Z; Liao Q; Wang H; Xiao Y; Wang W
    Cancer Cell Int; 2022 Jul; 22(1):240. PubMed ID: 35906593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA ADAMTS9-AS1 knockdown suppresses cell proliferation and migration in glioma through downregulating Wnt/β-catenin signaling pathway.
    Zhou C; Zhao H; Wang S; Dong C; Yang F; Zhang J
    Bosn J Basic Med Sci; 2022 Jun; 22(3):395-402. PubMed ID: 34923953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA LINC00460: Function and mechanism in human cancer.
    Chen X; Song J; Wang X; Sun D; Liu Y; Jiang Y
    Thorac Cancer; 2022 Jan; 13(1):3-14. PubMed ID: 34821482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of LINC00460 in the progression and prognosis in digestive tract tumors.
    Lin X; Zhou B; Ma J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Jun; 46(6):628-636. PubMed ID: 34275932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA ADAMTS9-AS1 knockdown restricts cell proliferation and EMT in non-small cell lung cancer.
    Li Z; Yue G; Zhang T; Wu J; Tian X
    Histol Histopathol; 2021 Oct; 36(10):1063-1072. PubMed ID: 34085704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction and Comparison of ceRNA Regulatory Network for Different Age Female Breast Cancer.
    Liu ZQ; Zhang GT; Jiang L; Li CQ; Chen QT; Luo DQ
    Front Genet; 2021; 12():603544. PubMed ID: 33968126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.